Dec 17, 2020 by Jason HawthorneForget Snowflake: 3 Hypergrowth Stocks I'd Rather BuyCompanies with fast growth and predictable trends are better bets in a frothy market.
Dec 16, 2020 by Jason HawthorneCould Trillium Fall Below $10 in 2021?A decline in the stock price plus positive clinical data equals opportunity.
Dec 16, 2020 by Jason HawthorneWhere Will CVS Health Be in 5 Years?Shareholders will have to be satisfied with playing defense in the future.
Dec 15, 2020 by Jason HawthorneCould Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?A winning culture and proven science should make this stock a winner.
Dec 15, 2020 by Jason HawthorneWhere Will CRISPR Therapeutics Be in 10 Years?This gene-editing leader's current programs only reveal a hint of what it could become.
Dec 15, 2020 by Jason HawthorneCould BioNTech Be a Millionaire-Maker Stock?To reward shareholders, the company is employing a common technology strategy.
Dec 13, 2020 by Jason HawthorneIf You Invested $1,000 in Teladoc in January, This Is How Much You'd Have NowThe telehealth stock has produced big returns for shareholders.
Dec 13, 2020 by Jason HawthorneNovavax Stock: Buy at the High?Two delays should have investors thinking twice about buying the stock.
Dec 13, 2020 by Jason HawthorneBuy, Sell, or Hold Moderna Stock at an All-Time High?More than just a rosy outlook for the COVID vaccine is priced into the shares.
Dec 12, 2020 by Jason Hawthorne3 Stocks That Are Giving Their Investors Coal in Their StockingsNaughty or nice, shareholders aren't getting anything on their wish lists from these stocks this year.
Dec 12, 2020 by Jason HawthorneIs Google's Healthcare Play a Dark Horse?The search giant is making a lot of moves that add up to a powerful offering for the healthcare industry.
Dec 11, 2020 by Jason HawthorneHere's What Investors Need To Know Before Buying Pfizer Stock For Its Coronavirus VaccineWith all eyes on its COVID vaccine candidate, another drug may have more impact on the company's fate -- and its stock price.
Dec 10, 2020 by Jason HawthorneHow Did Fulgent Genetics Stock Perform in 2020?The encore to a great 2019: Even more gains this year.
Dec 10, 2020 by Jason HawthorneUp Almost 2,000% in 2020, Is Vaxart Still a Buy?A COVID-19 vaccine in tablet form would be a game-changer in the fight against the pandemic.
Dec 10, 2020 by Jason HawthorneWhere to Invest $10,000 Right NowThis diverse group of stocks could offer investors peace of mind and profit in the years ahead.
Dec 10, 2020 by Jason HawthorneInvestors: How Would You Grade Gilead Sciences' CEO?The company has produced mixed results on the priorities the new CEO laid out when he took the helm last year.
Dec 10, 2020 by Jason HawthorneWhy Is Everyone Talking About Teladoc Stock?Recently-acquired Livongo's strong relationship with its customers and rapidly growing membership offer awesome potential for Teladoc's future.
Dec 10, 2020 by Jason Hawthorne3 Reasons to Buy Pfizer Stock NowThe company has a lot more going for it than just a coronavirus vaccine.
Dec 9, 2020 by Jason HawthorneArtificial Intelligence Just Revealed a Potential Concern for COVID Vaccine MakersVaccines are another part of the COVID-19 story related to demographics and race.
Dec 9, 2020 by Jason HawthorneIs Biogen Getting Desperate?The healthcare company made a curious move after a high-profile regulatory setback.
